Biologics Regulatory Spine Ventris Medical Announces the Award of Additional Patent Claims for its Novel Backpack Bone Graft Containment System byTim AllenMay 27, 2026
Biologics Spine Cerapedics Announces Supplier Agreement with Vizient for PearlMatrix® P-15 Peptide Enhanced Bone Graft byTim AllenApril 27, 2026
Regulatory Spine Medtronic Announces FDA approval of Infuse™ bone graft for one-and-two level Transforaminal Lumbar Interbody Fusion (TLIF) spine procedures byJosh SandbergFebruary 17, 2026
Biologics Regulatory Spine Top Stories Cerapedics’ PearlMatrix P-15 Peptide Enhanced Bone Graft, The First and Only Proven Bone Growth Accelerator, Now Approved for Expanded Indications for Use byTim AllenJanuary 13, 2026
Biologics Spine Cerapedics Announces Publication in Spine of 24-Month ASPIRE Study Results of PearlMatrix™ P-15 Peptide Enhanced Bone Graft byTim AllenDecember 17, 2025
Biologics Spine Sports Medicine Top Stories Xtant Medical Announces Commercial Launch of its Next-Generation nanOss Strata™ Synthetic Bone Graft byTim AllenDecember 11, 2025
Biologics Acuitive Technologies introduces Citregraft, a unique bone graft substitute designed to bind proteins and enhance regeneration byTim AllenNovember 26, 2025
Biologics Spine Cerapedics Announces First U.S. Patient Treated with PearlMatrix™ P-15 Peptide Enhanced Bone Graft following FDA approval byTim AllenJuly 8, 2025
Regulatory Spine Cerapedics Announces FDA Approval of PearlMatrix™ P-15 Peptide Enhanced Bone Graft, The First and Only Proven Bone Growth Accelerator for Lumbar Fusion byJosh SandbergJune 23, 2025
